Both in Pharmaceuticals
Journey Medical vs Nkarta
Over the past year DERM returned −37.0% and NKTX returned −25.5%; their daily moves had a correlation of 0.18.
DERM −37.0% NKTX −25.5%Growth of $1, one year, split-adjusted
| Metric | DERM | NKTX |
|---|---|---|
| Price | $5.12 | $1.72 |
| Market cap | $144.5M | $123.2M |
| Today | +3.23% | +1.18% |
| 1 month | −21.1% | −34.4% |
| 6 months | +2.4% | −36.1% |
| Year to date | −33.6% | −7.0% |
| 1 year | −36.2% | −26.8% |
| Revenue growth (YoY) | +18.9% | — |
| Gross margin | 65.6% | — |
| Net margin | −1.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.2× | — |
| Net cash | -$245.0K | $182.8M |
| Dividend yield | — | — |
| Volatility (60d) | 60.9% | 61.8% |
| Short % of float | 24.8% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).